Simris Group
0,129 SEK -1,53%1 investor følger denne virksomhed
Simris Group is a biotechnology company. The company is focused on research and development as well as the production of bioactive substances from cultured microalgae, for applications in nutrition, cosmeceuticals, and pharmaceuticals. The company's technology also replaces unsustainable raw materials from endangered species and sensitive marine ecosystems. The first product is omega-3 supplements that are sold under their own brand. Simris Group was founded in 2011 and is headquartered in Hammenhög.
Læs mereOmsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
SIMRIS B
Daglig lav / høj pris
0,12 / 0,14
SEK
Markedsværdi
44,73 mio. SEK
Aktieomsætning
6,99 t SEK
Volumen
55 t
Finanskalender
Delårsrapport
14.08.2024
Delårsrapport
13.11.2024
Årsrapport
26.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
SIX SIS AG, W8IMY | 19,1 % | 19,1 % |
Goldman Sachs & Co. LLC, W9 | 7,1 % | 7,1 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Bulletin from Simris Group AB (publ)’s Annual General Meeting
Notice of the Annual General Meeting of Simris Group AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools